Asia Pacific Cartilage Degeneration Market
Published On: Sep 2020
Published On: Sep 2020
Knee Segment Held Largest Share of Cartilage Degeneration Market in 2019
According to our new market research study on “Asia Pacific Cartilage Degeneration Market to 2027 – Regional Analysis and Forecast – by Procedure Type, Application and End User” the market is expected to reach US$ 2,509.24 million by 2027 from US$ 2,463.16 million in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific cartilage degeneration market and the factors driving the market growth along with those hindering it.
In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. Moreover, the prevalence of knee pain has witnessed massive growth of around 40.0% during past 4 decades. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
The growth of the Asia Pacific cartilage degeneration market is mainly attributed to growing number of sports injuries, and increasing prevalence of obesity. However, high cost of cartilage repair therapies is expected to restrict the market growth during the forecast period.
B. Braun Melsungen AG; Smith & Nephew; Stryker Corporation, CartiHeal, Inc.; and Vericel Corporation are among the leading companies operating in the Asia Pacific cartilage degeneration market.
The Report Segments Asia Pacific Cartilage Degeneration Market as Follows:
Asia Pacific Cartilage Degeneration Market – By Procedure Type
Asia Pacific Cartilage Degeneration Market – By Application
Asia Pacific Cartilage Degeneration Market – By End User
Asia Pacific Cartilage Degeneration Market – By Country
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
